The HTATIP2 tumour suppressor gene is characterized by an increased level of methylation in MM patients compared with patients with MGUS (Table 4), which (as we showed later in the study) resulted in a decrease in its expression (Table 5). This evidence concerns the gene HTATIP2 and Miyoshi myopathy.